Literature DB >> 29072951

Myxoinflammatory Fibroblastic Sarcoma: Review and Update.

David R Lucas1.   

Abstract

Myxoinflammatory fibroblastic sarcoma is a rare soft tissue tumor with most occurring in the distal extremities of adult patients. It has a high rate of local recurrence and a low rate of metastasis. Because it may appear benign on clinical examination, and because the microscopic features are generally underrecognized, it is often inadequately treated and misdiagnosed. In this review, based upon experience and that of the literature, the intent is to highlight salient clinicopathologic features, detail the broad microscopic spectrum including high-grade aggressive variants, review the molecular features, and discuss its relation to hemosiderotic fibrolipomatous tumor.

Entities:  

Mesh:

Year:  2017        PMID: 29072951     DOI: 10.5858/arpa.2017-0219-RA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  4 in total

1.  Myxoinflammatory Fibroblastic Sarcoma of the Parotid Gland: First Case Report and Literature Review.

Authors:  Changhong Wei; Xuejia Yang; Pingping Guo; Xiaoyu Chen; Chunjun Li; Jun Chen; Sufang Zhou
Journal:  Front Med (Lausanne)       Date:  2022-05-20

Review 2.  Epithelioid Cutaneous Mesenchymal Neoplasms: A Practical Diagnostic Approach.

Authors:  Joon Hyuk Choi; Jae Y Ro
Journal:  Diagnostics (Basel)       Date:  2020-04-17

3.  The first case of myxoinflammatory fibroblastic sarcoma affecting the maxillary bone.

Authors:  Çetin Boran; Asuman Kilitci; Hilal Ahsen; Fahri Yılmaz
Journal:  Int J Health Sci (Qassim)       Date:  2022 Mar-Apr

4.  Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases.

Authors:  David Suster; Michael Michal; Huiya Huang; Shira Ronen; Stephanie Springborn; Maria Debiec-Rychter; Steven D Billings; John R Goldblum; Brian P Rubin; Michal Michal; Saul Suster; A Craig Mackinnon
Journal:  Mod Pathol       Date:  2020-06-08       Impact factor: 7.842

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.